These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20804480)

  • 1. Inhibition of fatty acid amide hydrolase suppresses referred hyperalgesia induced by bladder inflammation.
    Merriam FV; Wang ZY; Hillard CJ; Stuhr KL; Bjorling DE
    BJU Int; 2011 Oct; 108(7):1145-9. PubMed ID: 20804480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of cystitis and pain sensation in mice lacking fatty acid amide hydrolase.
    Wang ZY; Wang P; Hillard CJ; Bjorling DE
    J Mol Neurosci; 2015 Apr; 55(4):968-76. PubMed ID: 25374388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.
    Charrua A; Matos R; Oliveira R; Marczylo T; Nagy I; Cruz F
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):263-272. PubMed ID: 31522241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lidocaine prevents referred hyperalgesia associated with cystitis.
    Guerios SD; Wang ZY; Boldon K; Bushman W; Bjorling DE
    Neurourol Urodyn; 2009; 28(5):455-60. PubMed ID: 19291783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
    J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of NGF and trk receptors inhibits increased peripheral mechanical sensitivity accompanying cystitis in rats.
    Guerios SD; Wang ZY; Boldon K; Bushman W; Bjorling DE
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R111-22. PubMed ID: 18448607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats.
    Strittmatter F; Gandaglia G; Benigni F; Bettiga A; Rigatti P; Montorsi F; Gratzke C; Stief C; Colciago G; Hedlund P
    Eur Urol; 2012 Jan; 61(1):98-106. PubMed ID: 21930339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
    Naidu PS; Kinsey SG; Guo TL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2010 Jul; 334(1):182-90. PubMed ID: 20375198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma.
    Jian W; Edom R; Weng N; Zannikos P; Zhang Z; Wang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1687-99. PubMed ID: 20462810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.
    Sasso O; Wagner K; Morisseau C; Inceoglu B; Hammock BD; Piomelli D
    Pharmacol Res; 2015 Jul; 97():7-15. PubMed ID: 25882247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
    Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
    Karbarz MJ; Luo L; Chang L; Tham CS; Palmer JA; Wilson SJ; Wennerholm ML; Brown SM; Scott BP; Apodaca RL; Keith JM; Wu J; Breitenbucher JG; Chaplan SR; Webb M
    Anesth Analg; 2009 Jan; 108(1):316-29. PubMed ID: 19095868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM; Guindon J; Hohmann AG
    Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats.
    Jones MR; Wang ZY; Bjorling DE
    Am J Clin Exp Urol; 2015; 3(1):28-35. PubMed ID: 26069885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with a cannabinoid receptor 2 agonist decreases severity of established cystitis.
    Wang ZY; Wang P; Bjorling DE
    J Urol; 2014 Apr; 191(4):1153-8. PubMed ID: 24184363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
    Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
    Mol Pain; 2016; 12():. PubMed ID: 27178246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
    Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K
    Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.
    Nasirinezhad F; Jergova S; Pearson JP; Sagen J
    Neuropharmacology; 2015 Aug; 95():100-9. PubMed ID: 25486617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.